Infection control device company Vioguard said today it raised $5 million in a Series A round of financing, with funds slated to support expanded sales and marketing and accelerated product development.
The round for the Bothwell, Wash.-based company was led by Imagen Capital Partners, and brings the total raised for the company to $11 million. As part of the funding, Imagen Capital Partners will get 2 seats on Vioguard’s board of directors.
“We are excited about Vioguard’s technology platform and its leadership team as they continue their efforts to bring pioneering UV-C solutions to the worldwide marketplace,” Imagen Capital Partners managing director Chris Barrow said in a prepared statement.
Vioguard produces ultraviolet disinfection technology solutions, including its flagship self-sanitizing automatic keyboard and mouse system which sanitizes using high-powered germicidal ultraviolet light known as UV-C. The system has FDA 510(k) clearance and kills 99.99% of bacteria, viruses, fungi and drug-resistant pathogens, the company said.
“I believe the investment by Imagen will help Vioguard advance our leadership position within the ultraviolet disinfection arena. We are pleased to welcome Imagen Capital Partners as a shareholder and look forward to an exciting and prosperous future with them,” CEO & prez Laurance Ranta said in a press release.
Vioguard said the funding will help enable it to develop products and pursue its current business strategy. The company said it expects to introduce additional products, including an escalator handrail sanitizer and pen sterilizing device, some time in 2017.
The post Vioguard raises $5m in Series A to support ultraviolet disinfection tech appeared first on MassDevice.
from MassDevice http://ift.tt/2kkkwuG
Cap comentari:
Publica un comentari a l'entrada